{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:13:10Z","timestamp":1760955190262},"reference-count":124,"publisher":"Oxford University Press (OUP)","issue":"1015","license":[{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tongue cancer, one of the most common malignant cancers of the oral cavity, still affects human health worldwide due to its disappointing survival rates, despite significant developments in its multimodality treatment. The predominant cause of death in patients with tongue cancer is the high occurrence of invasion to surrounding tissues, lymph and distant metastasis, and recurrence. Due to the limited value of conventional predictive and prognostic factors and the uniformity of treatment strategies, several patients are still over- or under-treated, with significantly personal and socioeconomic impact. This review focuses on some promising predictive and prognostic biomarkers of tongue cancer and their actual\/potential clinical implications, in order to provide clinicians with useful information for the improvement of early diagnostic\/prognostic evaluation and management of patients with tongue cancer.<\/jats:p>","DOI":"10.1136\/pgmj.2009.086504","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T01:57:33Z","timestamp":1271296653000},"page":"292-298","source":"Crossref","is-referenced-by-count":12,"title":["Biomarkers in tongue cancer: understanding the molecular basis and their clinical implications"],"prefix":"10.1093","volume":"86","author":[{"given":"Min","family":"Zheng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University , Chengdu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University , Chengdu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ling","family":"Tang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University , Chengdu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-hua","family":"Liang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University , Chengdu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"2023041908594022900_b1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hed.20758","article-title":"Association of tumor satellite distance with prognosis and contralateral neck recurrence of tongue squamous cell carcinoma","volume":"30","author":"Yang","year":"2008","journal-title":"Head Neck"},{"key":"2023041908594022900_b2","first-page":"293","article-title":"An orthotopic nude mouse model of oral tongue squamous cell carcinoma","volume":"8","author":"Myers","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2023041908594022900_b3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.archoralbio.2008.06.010","article-title":"Establishment of a highly metastatic tongue squamous cell carcinoma cell line from New Zealand White rabbit","volume":"53","author":"Wulong","year":"2008","journal-title":"Arch Oral Biol"},{"key":"2023041908594022900_b4","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00029330-200810010-00004","article-title":"Occult cervical lymph node metastases in 100 consecutive patients with cN0 tongue cancer","volume":"121","author":"Jin","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"2023041908594022900_b5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.oraloncology.2005.11.012","article-title":"Higher distant failure in young age tongue cancer patients","volume":"42","author":"Liao","year":"2006","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tripleo.2003.12.041","article-title":"Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome","volume":"98","author":"Gorsky","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2023041908594022900_b7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5357\/koubyou.62.532","volume":"62","author":"Sato","year":"1995","journal-title":"Kokubyo Gakkai Zasshi"},{"key":"2023041908594022900_b8","first-page":"1177","article-title":"Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue","volume":"26","author":"Ekberg","year":"2005","journal-title":"Int J Oncol"},{"key":"2023041908594022900_b9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/172460080602100202","article-title":"p53 expression in leukoplakia and carcinoma of the tongue","volume":"21","author":"Vora","year":"2006","journal-title":"Int J Biol Markers"},{"key":"2023041908594022900_b10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijrobp.2009.03.003","article-title":"Biomarkers for response to neoadjuvant chemoradiation for rectal cancer","volume":"74","author":"Kuremsky","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023041908594022900_b11","first-page":"1059","article-title":"Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling","volume":"29","author":"Katayama","year":"2009","journal-title":"Anitcancer Res"},{"key":"2023041908594022900_b12","first-page":"1987","article-title":"Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474)","volume":"29","author":"Sienmann","year":"2009","journal-title":"Anticancer Res"},{"key":"2023041908594022900_b13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.cgt.7700562","article-title":"Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer","volume":"10","author":"Wen","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"2023041908594022900_b14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jinorgbio.2006.11.003","article-title":"Towards bioreductively activated prodrugs: Fe(III) complexes of hydroxamic acids and the MMP inhibitor marimastat","volume":"101","author":"Failes","year":"2007","journal-title":"J Inorg Biochem"},{"key":"2023041908594022900_b15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1288\/00005537-198311000-00010","article-title":"Oncogenes: preliminary studies in head and neck cancer","volume":"93","author":"Friedman","year":"1983","journal-title":"Laryngoscope"},{"key":"2023041908594022900_b16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1601-0825.2009.01529.x","article-title":"Current concepts in research related to oncogenes implicated in salivary gland tumourigenesis: a review of the literature","volume":"15","author":"Elledge","year":"2009","journal-title":"Oral Dis"},{"key":"2023041908594022900_b17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0964-1955(95)00045-3","article-title":"Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance","volume":"31","author":"Riva","year":"1995","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"2023041908594022900_b18","doi-asserted-by":"crossref","first-page":"18794","DOI":"10.1073\/pnas.0806879105","article-title":"Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023041908594022900_b19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jso.20675","article-title":"Expression of C-Myc mRNA in squamous cell carcinoma of the tongue","volume":"95","author":"Vora","year":"2007","journal-title":"J Surg Oncol"},{"key":"2023041908594022900_b20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"Soucek","year":"2008","journal-title":"Nature"},{"key":"2023041908594022900_b21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2334\/josnusd.47.71","article-title":"Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions","volume":"47","author":"Turatti","year":"2005","journal-title":"J Oral Sci"},{"key":"2023041908594022900_b22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjc.6604650","article-title":"C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma","volume":"99","author":"Mahner","year":"2008","journal-title":"Br J Cancer"},{"key":"2023041908594022900_b23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1440-1827.2003.01587.x","article-title":"Expressions of junB and c-fos are enhanced in 4-nitroquinoline 1-oxide-induced rat tongue cancers","volume":"54","author":"Ohyama","year":"2004","journal-title":"Pathol Int"},{"key":"2023041908594022900_b24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.0904-2512.2001.10012.x","article-title":"Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma","volume":"31","author":"de Sousa","year":"2002","journal-title":"J Oral Pathol Med"},{"key":"2023041908594022900_b25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","article-title":"Human papillomavirus: epidemiology and public health","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"2023041908594022900_b26","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D' Souza","year":"2007","journal-title":"N Engl J Med"},{"key":"2023041908594022900_b27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.oraloncology.2007.09.004","article-title":"HPV16 transmission between a couple with HPV-related head and neck cancer","volume":"44","author":"Haddad","year":"2008","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b28","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.jcv.2004.11.017","article-title":"Human papillomavirus (HPV) in head and neck cancer","volume":"32","author":"Syrj\u00e4nen","year":"2005","journal-title":"J Clin Virol"},{"key":"2023041908594022900_b29","first-page":"829","article-title":"Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer","volume":"26","author":"Dahlgren","year":"2006","journal-title":"Anticancer Res"},{"key":"2023041908594022900_b30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archoto.2009.6","article-title":"Chronic periodontitis-human papillomavirus synergy in base of tongue cancers","volume":"135","author":"Tezal","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2023041908594022900_b31","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.joms.2008.04.009","article-title":"Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience","volume":"66","author":"Liang","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl 1","key":"2023041908594022900_b32","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2007.11.069","article-title":"Cervical cancer screening following prophylactic human papillomavirus vaccination","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"key":"2023041908594022900_b33","first-page":"532","volume":"145","author":"Michalov\u00e1","year":"2006","journal-title":"Cas Lek Cesk"},{"key":"2023041908594022900_b34","first-page":"325","volume":"16","author":"Berbe\u0107","year":"1997","journal-title":"Postepy Hig Med Dosw"},{"key":"2023041908594022900_b35","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1073\/pnas.90.23.10914","article-title":"Antioncogenes and human cancer","volume":"90","author":"Knudson","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023041908594022900_b36","first-page":"334","volume":"23","author":"Liao","year":"2004","journal-title":"Ai Zheng"},{"key":"2023041908594022900_b37","first-page":"83","article-title":"Transcriptional inhibitors, p53 and apoptoss","volume":"1786","author":"Gartel","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"2023041908594022900_b38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcms.2005.05.004","article-title":"p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival","volume":"33","author":"Kozomara","year":"2005","journal-title":"J Craniomaxillofac Surg"},{"key":"2023041908594022900_b39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<415::AID-PATH548>3.0.CO;2-1","article-title":"p53 gene alternations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma","volume":"178","author":"Kusama","year":"1996","journal-title":"J Pathol"},{"key":"2023041908594022900_b40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1293\/tox.15.209","article-title":"Tongue carcinogenic susceptibility of p53 deficient mice to methyl-n-amylnitrosamine","volume":"15","author":"Shirai","year":"2002","journal-title":"J Toxicol Pathol"},{"key":"2023041908594022900_b41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/CAD.0b013e32832a2df9","article-title":"Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial","volume":"20","author":"Tian","year":"2009","journal-title":"Anticancer Drugs"},{"key":"2023041908594022900_b42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1631\/jzus.B0820248","article-title":"Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up","volume":"10","author":"Guan","year":"2009","journal-title":"J Zhejiang Univ Sci B"},{"key":"2023041908594022900_b43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/ejso.1999.0895","article-title":"Current role of gene therapy in head and neck cancer","volume":"26","author":"Ganly","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"2023041908594022900_b44","first-page":"6359","article-title":"Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial","volume":"60","author":"Nemunaitis","year":"2000","journal-title":"Cancer Res"},{"key":"2023041908594022900_b45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000","journal-title":"Nat Med"},{"key":"2023041908594022900_b46","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1093\/nar\/gng092","article-title":"Detection of methylation of human p16(Ink4a) gene 5'-CpG islands by electrochemical method coupled with linker-PCR","volume":"31","author":"Hou","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2023041908594022900_b47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2407-7-47","article-title":"Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas","volume":"7","author":"Ivanova","year":"2007","journal-title":"BMC Cancer"},{"key":"2023041908594022900_b48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijom.2005.08.005","article-title":"Detection of p16 promoter methylation in the serum of oral cancer patients","volume":"35","author":"Nakahara","year":"2006","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2023041908594022900_b49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.oraloncology.2005.11.011","article-title":"Selective loss of resistant alleles at p15INK4B and p16INK4A genes in chemically-induced rat tongue cancers","volume":"42","author":"Ogawa","year":"2006","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/AJCP61KNVHJVHAFN","article-title":"p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma","volume":"132","author":"Nakazawa","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"2023041908594022900_b51","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/onc.2008.239","article-title":"PTEN signaling in brain: neuropathology and tumorigenesis","volume":"27","author":"Endersby","year":"2008","journal-title":"Oncogene"},{"key":"2023041908594022900_b52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1054\/bjoc.2001.1848","article-title":"Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus","volume":"84","author":"Snaddon","year":"2001","journal-title":"Br J Cancer"},{"key":"2023041908594022900_b53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.67.1.481","article-title":"Phosphoinositide kinases","volume":"67","author":"Fruman","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2023041908594022900_b54","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-0215(19980831)77:5<684::AID-IJC4>3.0.CO;2-R","article-title":"Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma","volume":"77","author":"Shao","year":"1998","journal-title":"Int J Cancer"},{"key":"2023041908594022900_b55","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archotol.127.12.1441","article-title":"Loss of PTEN expression as a prognostic marker for tongue cancer","volume":"127","author":"Lee","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2023041908594022900_b56","first-page":"549","volume":"41","author":"Yang","year":"2006","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2023041908594022900_b57","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/sj.gt.3302100","article-title":"Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo","volume":"10","author":"Saito","year":"2003","journal-title":"Gene Ther"},{"key":"2023041908594022900_b58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.cgt.7701050","article-title":"Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity","volume":"14","author":"Pappas","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"2023041908594022900_b59","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/cncr.21476","article-title":"Akt activation correlates with adverse outcome in tongue cancer","volume":"104","author":"Massarelli","year":"2005","journal-title":"Cancer"},{"key":"2023041908594022900_b60","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4161\/cbt.5.7.2874","article-title":"A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer","volume":"5","author":"Argiris","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"2023041908594022900_b61","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.2741\/3152","article-title":"Cytokine regulation networks in the cancer microenvironment","volume":"13","author":"Sheu","year":"2008","journal-title":"Front Biosci"},{"key":"2023041908594022900_b62","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ar.20893","article-title":"Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma","volume":"292","author":"Guo","year":"2009","journal-title":"Anat Rec (Hoboken)"},{"key":"2023041908594022900_b63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"2023041908594022900_b64","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.oraloncology.2008.01.018","article-title":"Expression of EphA2 and VEGF in Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcomesquamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome","volume":"44","author":"Shao","year":"2008","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jso.20461","article-title":"Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression","volume":"93","author":"Kim","year":"2006","journal-title":"J Surg Oncol"},{"key":"2023041908594022900_b66","first-page":"389","article-title":"The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma","volume":"14","author":"Tanigaki","year":"2004","journal-title":"Int J Mol Med"},{"key":"2023041908594022900_b67","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-08-2568","article-title":"Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer","volume":"15","author":"Hanrahan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2023041908594022900_b68","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/era.09.96","article-title":"Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer","volume":"9","author":"Merseburger","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"2023041908594022900_b69","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00330-006-0425-9","article-title":"The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients","volume":"17","author":"Meijerink","year":"2007","journal-title":"Eur Radiol"},{"key":"2023041908594022900_b70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.11.008","article-title":"Functional selectivity of EGF family peptide growth factors: implications for cancer","volume":"122","author":"Wilson","year":"2009","journal-title":"Pharmacol Ther"},{"key":"2023041908594022900_b71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fon.09.10","article-title":"EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma","volume":"5","author":"Hudson","year":"2009","journal-title":"Future Oncol"},{"key":"2023041908594022900_b72","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejca.2009.02.027","article-title":"EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma","volume":"45","author":"Ryott","year":"2009","journal-title":"Eur J Cancer"},{"key":"2023041908594022900_b73","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"2023041908594022900_b74","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","article-title":"Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study","volume":"23","author":"Burtness","year":"2005","journal-title":"J Clin Oncol"},{"key":"2023041908594022900_b75","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2169\/internalmedicine.48.2401","article-title":"Gefitinib for non-small cell lung cancer patients with liver cirrhosis","volume":"48","author":"Kim","year":"2009","journal-title":"Intern Med"},{"key":"2023041908594022900_b76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3835(03)00464-6","article-title":"Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells","volume":"201","author":"Shintani","year":"2003","journal-title":"Cancer Lett"},{"key":"2023041908594022900_b77","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1213\/01.ane.0000198330.84341.35","article-title":"The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor","volume":"102","author":"Sakaguchi","year":"2006","journal-title":"Anesth Analg"},{"key":"2023041908594022900_b78","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11033-008-9256-x","article-title":"Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma","volume":"36","author":"Wang","year":"2009","journal-title":"Mol Biol Rep"},{"key":"2023041908594022900_b79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1541-7786.MCR-07-0208","article-title":"Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression","volume":"6","author":"Sun","year":"2008","journal-title":"Mol Cancer Res"},{"key":"2023041908594022900_b80","first-page":"376","volume":"36","author":"Liu","year":"2001","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"2023041908594022900_b81","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jcb.20647","article-title":"Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells","volume":"97","author":"Dasgupta","year":"2006","journal-title":"J Cell Biochem"},{"key":"2023041908594022900_b82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2009.01.033","article-title":"Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9","volume":"279","author":"Ho","year":"2009","journal-title":"Cancer Lett"},{"key":"2023041908594022900_b83","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1158\/0008-5472.CAN-05-4478","article-title":"Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1","volume":"66","author":"Oku","year":"2006","journal-title":"Cancer Res"},{"key":"2023041908594022900_b84","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.oraloncology.2004.01.006","article-title":"Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue","volume":"40","author":"Guttman","year":"2004","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b85","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.4049\/jimmunol.0801935","article-title":"Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade","volume":"182","author":"Rand","year":"2009","journal-title":"J Immunol"},{"key":"2023041908594022900_b86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anl.2007.12.002","article-title":"A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer","volume":"35","author":"Shimizu","year":"2008","journal-title":"Auris Nasus Larynx"},{"key":"2023041908594022900_b87","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/1097-0215(20010120)95:1<44::AID-IJC1008>3.0.CO;2-M","article-title":"Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma","volume":"95","author":"Yoshizaki","year":"2001","journal-title":"Int J Cancer"},{"key":"2023041908594022900_b88","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/154405910208101207","article-title":"MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells","volume":"81","author":"Nyberg","year":"2002","journal-title":"J Dent Res"},{"key":"2023041908594022900_b89","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.bjc.6604239","article-title":"Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer","volume":"98","author":"Korpi","year":"2008","journal-title":"Br J Cancer"},{"key":"2023041908594022900_b90","doi-asserted-by":"crossref","first-page":"22404","DOI":"10.1074\/jbc.M210325200","article-title":"Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13","volume":"278","author":"Nyberg","year":"2003","journal-title":"J Biol Chem"},{"key":"2023041908594022900_b91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000163217","article-title":"In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts","volume":"71","author":"Skipper","year":"2009","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2023041908594022900_b92","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vph.2007.08.009","article-title":"Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression","volume":"47","author":"Lee","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"2023041908594022900_b93","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023041908594022900_b94","first-page":"869","article-title":"Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact","volume":"24","author":"Hildenbrand","year":"2009","journal-title":"Histol Histopathol"},{"key":"2023041908594022900_b95","first-page":"150","volume":"21","author":"Liang","year":"2003","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"2023041908594022900_b96","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.oraloncology.2008.03.004","article-title":"RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells","volume":"44","author":"Liang","year":"2008","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b97","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.24360","article-title":"RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma","volume":"125","author":"Zhou","year":"2009","journal-title":"Int J Cancer"},{"key":"2023041908594022900_b98","first-page":"889","article-title":"The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model","volume":"5","author":"Pilat","year":"1998","journal-title":"Oncol Rep"},{"key":"2023041908594022900_b99","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/000313480006600507","article-title":"Suppression of the invasive capacity of human breast cancer cells by inhibition of urokinase plasminogen activator via amiloride and B428","volume":"66","author":"Evans","year":"2000","journal-title":"Am Surg"},{"key":"2023041908594022900_b100","first-page":"489","article-title":"Effects of amiloride and bumetanide on hyperpolarization after movement across the distal colon epithelium","volume":"57","author":"Mlodzik-Danielewicz","year":"2005","journal-title":"Pharmacol Rep"},{"key":"2023041908594022900_b101","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1349-7006.2003.tb01395.x","article-title":"Tumor hypoxia: a target for selective cancer therapy","volume":"94","author":"Kizaka-Kondoh","year":"2003","journal-title":"Cancer Sci"},{"key":"2023041908594022900_b102","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ijc.23647","article-title":"Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells","volume":"123","author":"Yao","year":"2008","journal-title":"Int J Cancer"},{"key":"2023041908594022900_b103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.critrevonc.2009.01.001","article-title":"Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives","volume":"70","author":"Otrock","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"2023041908594022900_b104","first-page":"1659","article-title":"Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis\/angiogenesis in oral squamous cell carcinoma","volume":"28","author":"Liang","year":"2008","journal-title":"Anticancer Res"},{"key":"2023041908594022900_b105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.oraloncology.2008.03.017","article-title":"The prognostic value of hypoxia markers in T2-staged oral tongue cancer","volume":"45","author":"Roh","year":"2009","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vph.2009.05.005","article-title":"HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation","volume":"51","author":"Loboda","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"2023041908594022900_b107","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ijc.20334","article-title":"Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas","volume":"111","author":"Zhang","year":"2004","journal-title":"Int J Cancer"},{"key":"2023041908594022900_b108","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/pros.20488","article-title":"Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis","volume":"66","author":"Xu","year":"2006","journal-title":"Prostate"},{"key":"2023041908594022900_b109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","article-title":"EMT, the cytoskeleton, and cancer cell invasion","volume":"28","author":"Yilmaz","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"2023041908594022900_b110","first-page":"1133","article-title":"Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1\/CXCR4 system in oral squamous cell carcinoma cells","volume":"29","author":"Onoue","year":"2006","journal-title":"Int J Oncol"},{"key":"2023041908594022900_b111","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/138955708784223521","article-title":"E-cadherin upregulation as a therapeutic goal in cancer treatment","volume":"8","author":"Howard","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"2023041908594022900_b112","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","article-title":"E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer","volume":"28","author":"Schmalhofer","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"2023041908594022900_b113","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0714.1999.tb02006.x","article-title":"Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo","volume":"28","author":"Hoteiya","year":"1999","journal-title":"J Oral Pathol Med"},{"key":"2023041908594022900_b114","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.oraloncology.2005.07.010","article-title":"Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma","volume":"42","author":"Diniz-Freitas","year":"2006","journal-title":"Oral Oncol"},{"key":"2023041908594022900_b115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cncr.10211","article-title":"Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance","volume":"94","author":"Chang","year":"2002","journal-title":"Cancer"},{"key":"2023041908594022900_b116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s004320000177","article-title":"A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma","volume":"172","author":"Chow","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"2023041908594022900_b117","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1242\/jcs.021782","article-title":"Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium","volume":"121","author":"Diamond","year":"2008","journal-title":"J Cell Sci"},{"key":"2023041908594022900_b118","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BC20060020","article-title":"Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells","volume":"98","author":"Duan","year":"2006","journal-title":"Biol Cell"},{"key":"2023041908594022900_b119","first-page":"1223","article-title":"An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells","volume":"21","author":"Li","year":"2009","journal-title":"Oncol Rep"},{"key":"2023041908594022900_b120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1440-1789.2003.00511.x","article-title":"Cytokeratin 7 and 20 as immunohistochemical markers in identification of primary tumors in craniospinal metastases: do they have a significant role?","volume":"23","author":"Taweevisit","year":"2002","journal-title":"Neuropathology"},{"key":"2023041908594022900_b121","first-page":"757","article-title":"Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors","volume":"23","author":"Di Carlo","year":"2003","journal-title":"Int J Oncol"},{"key":"2023041908594022900_b122","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2230.2008.02898.x","article-title":"Epidermotropic skin metastasis from gastric cancer: immunohistochemical analysis using cytokeratins","volume":"34","author":"Hayashi","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"2023041908594022900_b123","first-page":"215","article-title":"Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence","volume":"26","author":"Yanagawa","year":"2007","journal-title":"J Exp Clin Cancer Res"},{"key":"2023041908594022900_b124","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9440(10)65002-X","article-title":"Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability","volume":"156","author":"Morifuji","year":"2000","journal-title":"Am J Pathol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/86\/1015\/292\/50022479\/postgradmedj-86-292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/86\/1015\/292\/50022479\/postgradmedj-86-292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:15:57Z","timestamp":1681895757000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/86\/1015\/292\/7007313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":124,"journal-issue":{"issue":"1015","published-online":{"date-parts":[[2010,4,14]]},"published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2009.086504","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,5]]},"published":{"date-parts":[[2010,4,14]]}}}